Cyted Health today announced positive clinical validation data from DETECT-ME, a prospective, multicenter study of the EndoSign® Barrett’s Esophagus (BE) Test. Conducted at 18 U.S. clinical sites, the ...

New studies presented at ACG 2026 indicate TissueCypher offers objective risk assessment for Barrett’s esophagus progression ...

A novel DNA methylation test using the EndoSign capsule-sponge detected Barrett’s esophagus with 90% sensitivity and 86% ...

Cyted Health will present clinical validation data from DETECT-ME, a prospective, 18-site U.S. study of the EndoSign ® ...

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today ...

Dr. Raja Flores, a leading thoracic surgeon with the Mount Sinai Health System, explains why routine screening for esophageal cancer is not recommended for average-risk people, though higher-risk ...

Castle Biosciences, Inc. announced that new data from three studies evaluating its TissueCypher Barrett's Esophagus (BE) test will be presented at the American College of Gastroenterology (ACG) 2026 ...

The reality star shares her concern that she could develop cancer after being diagnosed with a disease of her digestive tract ...

Kim Kardashian's health scare could turn deadly in 15 years — just like her father's did. Discover what doctors told her.

Kim Kardashian’s latest health scare has her family rattled. In a trailer for “The Kardashians” Season 8 dropped in Friday, the Skims founder, 45, revealed that she has “something called esophagitis.” ...

Kim Kardashian reveals her esophagitis diagnosis in a new "Kardashians" trailer, raising fears tied to her father's esophageal cancer death.

Kim Kardashian reveals she has been diagnosed with esophagitis in a new trailer for "The Kardashians." The condition, left untreated, can lead to the same cancer that killed her dad.